This gene encodes an antigen that is preferentially expressed in human melanomas and that is recognized by cytolytic T lymphocytes. It is not expressed in normal tissues, except testis. The encoded protein acts as a repressor of retinoic acid receptor, and likely confers a growth advantage to cancer cells via this function. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014]
此基因编码在人黑素瘤中优先表达,而且是由细胞毒性T淋巴细胞识别的抗原。它不是在正常组织中表达,除了睾丸。所编码的蛋白质作为视黄酸受体的阻遏,并有可能通过该功能赋予生长优势到癌细胞。选择性剪接结果在多个抄本变形。 [由RefSeq的,2014年4月提供]
PRAME基因(以及对应的蛋白质)的细胞分布位置:
PRAME基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
leukemia | 0.125981653 | 14 | 0 | BeFree_CTD_human_LHGDN |
Myeloid Leukemia, Chronic | 0.122171535 | 8 | 0 | BeFree_CTD_human |
melanoma | 0.121900093 | 7 | 0 | BeFree_CTD_human |
Medulloblastoma | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Multiple Myeloma | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Sarcoma | 0.12 | 1 | 0 | CTD_human |
Non-Small Cell Lung Carcinoma | 0.12 | 1 | 0 | CTD_human |
Head and Neck Neoplasms | 0.12 | 1 | 0 | CTD_human |
Renal Cell Carcinoma | 0.12 | 1 | 0 | CTD_human |
Neoplasm, Residual | 0.008434561 | 11 | 0 | BeFree_LHGDN |
关注微信订阅号,实时查看信息,关注医学生物学动态。